177 related articles for article (PubMed ID: 11979191)
1. Metronidazole gel in managing malodorous fungating wounds.
Clark J
Br J Nurs; 2002 Mar; 11(6 Suppl):S54-60. PubMed ID: 11979191
[TBL] [Abstract][Full Text] [Related]
2. The management of malodour and exudate in fungating wounds.
Draper C
Br J Nurs; 2005 Jun 9-22; 14(11):S4-12. PubMed ID: 15976610
[TBL] [Abstract][Full Text] [Related]
3. A topical metronidazole gel used to treat malodorous wounds.
Bale S; Tebbie N; Price P
Br J Nurs; 2004 Jun; 13(11):S4-11. PubMed ID: 15218439
[TBL] [Abstract][Full Text] [Related]
4. Topical metronidazole for the treatment of wound odor: a review of the literature.
Paul JC; Pieper BA
Ostomy Wound Manage; 2008 Mar; 54(3):18-27; quiz 28-9. PubMed ID: 18382045
[TBL] [Abstract][Full Text] [Related]
5. Malignant fungating wounds: assessment and management.
Dowsett C
Br J Community Nurs; 2002 Aug; 7(8):394-400. PubMed ID: 12192342
[TBL] [Abstract][Full Text] [Related]
6. Using wound bed preparation to heal a malignant fungating wound: a single case study.
Lo SF; Hsu MY; Hu WY
J Wound Care; 2007 Oct; 16(9):373-6. PubMed ID: 17987748
[TBL] [Abstract][Full Text] [Related]
7. Symptom burden and quality of life in patients with malignant fungating wounds.
Lo SF; Hayter M; Hu WY; Tai CY; Hsu MY; Li YF
J Adv Nurs; 2012 Jun; 68(6):1312-21. PubMed ID: 22043819
[TBL] [Abstract][Full Text] [Related]
8. Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75 % gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013).
Watanabe K; Shimo A; Tsugawa K; Tokuda Y; Yamauchi H; Miyai E; Takemura K; Ikoma A; Nakamura S
Support Care Cancer; 2016 Jun; 24(6):2583-90. PubMed ID: 26715293
[TBL] [Abstract][Full Text] [Related]
9. Fungating wounds: management and treatment options.
Tandler S; Stephen-Haynes J
Br J Nurs; 2017 Jun; 26(12 Suppl):S6-S14. PubMed ID: 28640720
[TBL] [Abstract][Full Text] [Related]
10. Metrotop: a topical antimicrobial agent for malodorous wounds.
Moody M
Br J Nurs; 1998 Mar 12-25; 7(5):286-9. PubMed ID: 9616550
[TBL] [Abstract][Full Text] [Related]
11. Wound infection and colonisation.
Scanlon E
Nurs Stand; 2005 Feb 23-Mar 1; 19(24):57-8, 60, 62 passim. PubMed ID: 15754927
[TBL] [Abstract][Full Text] [Related]
12. [Palliative care of exulceration of tumor wounds. Permitting the personal shock].
Uebach B; Kern M
Pflege Z; 2011 Oct; 64(10):606-10. PubMed ID: 22032035
[No Abstract] [Full Text] [Related]
13. Malignant cutaneous wounds.
Schiech L
Clin J Oncol Nurs; 2002; 6(5):305-9. PubMed ID: 12240496
[TBL] [Abstract][Full Text] [Related]
14. A double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours.
Bower M; Stein R; Evans TR; Hedley A; Pert P; Coombes RC
Eur J Cancer; 1992; 28A(4-5):888-9. PubMed ID: 1524917
[TBL] [Abstract][Full Text] [Related]
15. Case study: eliminating odors from wounds.
Poteete V
Decubitus; 1993 Jul; 6(4):43-6. PubMed ID: 8297491
[TBL] [Abstract][Full Text] [Related]
16. Assessment and management of fungating wounds: a review.
Wilson V
Br J Community Nurs; 2005 Mar; 10(3):S28-34. PubMed ID: 15824709
[TBL] [Abstract][Full Text] [Related]
17. The effect of topical 0.75% metronidazole gel on malodorous cutaneous ulcers.
Finlay IG; Bowszyc J; Ramlau C; Gwiezdzinski Z
J Pain Symptom Manage; 1996 Mar; 11(3):158-62. PubMed ID: 8851373
[TBL] [Abstract][Full Text] [Related]
18. [How effective are silver wound dressings? Wound healing of critically colonized and infected wounds].
Heuckeroth L; Palm R
Pflege Z; 2013 Jun; 66(6):362-5. PubMed ID: 23798176
[No Abstract] [Full Text] [Related]
19. Experiences of living with a malignant fungating wound: a qualitative study.
Lo SF; Hu WY; Hayter M; Chang SC; Hsu MY; Wu LY
J Clin Nurs; 2008 Oct; 17(20):2699-708. PubMed ID: 18808638
[TBL] [Abstract][Full Text] [Related]
20. [Bacteriological samples from wounds].
Fromantin I; Kriegel I; Cuzon F
Soins; 2009 Jun; (736):28, 30-2. PubMed ID: 19670677
[No Abstract] [Full Text] [Related]
[Next] [New Search]
